AMRX achieved a dramatic turnaround from a $116.9M net loss to $72.1M net income while significantly strengthening its balance sheet with cash increasing 155% and current liabilities declining 22%.
This represents a fundamental transformation in AMRX's financial performance, with the company moving from deeply unprofitable to solidly profitable operations. The simultaneous improvement in cash position and reduction in current liabilities suggests much stronger operational execution and liquidity management, though stockholders equity remains negative, indicating the company is still recovering from previous difficulties.
AMRX delivered exceptional financial improvement across nearly all metrics, with the most striking being the $189M swing from net loss to net income, supported by 58% growth in operating income and 15% growth in operating cash flow. The balance sheet showed significant strengthening with cash more than doubling to $282M while current liabilities decreased by $218M, though stockholders equity remained negative at -$70.8M. The overall picture signals a company that has successfully executed a major operational turnaround, moving from financial distress to profitability and improved liquidity, though full balance sheet recovery is still in progress.
Net income grew 161.6% — bottom-line growth signals improving overall business health.
Cash position surged 155.1% — strong cash generation or capital raise providing significant financial cushion.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Equity base grew 35.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Capital expenditure jumped 34.9% — major investment cycle underway; assess returns on deployment.
Current liabilities reduced — improved short-term financial position and working capital health.
Current assets grew 20.4% — improving short-term liquidity or inventory/receivables build.
Operating cash flow grew 15.2% — strong conversion of earnings to cash, healthy business fundamentals.
Receivables grew 12% — monitor days sales outstanding for collection efficiency.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →